Imodium Classic

Loperamide Hydrochloride, the active ingredient in Imodium Classic, is an antidiarrheal presented as an oral tablet for oral use. It reduces intestinal motility and secretion to relieve diarrhea in adults and children when appropriate.

GNH USA supplies Imodium Classic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imodium Classic is an antidiarrheal that acts on the gastrointestinal tract to control excess stool output. - Acute nonspecific diarrhea: decreases stool frequency and urgency. - Travelers' diarrhea: provides symptomatic relief during short‑term travel‑related episodes. - Chronic diarrhea associated with inflammatory bowel disease: helps manage persistent loose stools.

Common Side Effects: - Constipation: reduced bowel movements may become pronounced. - Abdominal cramps: mild to moderate discomfort in the abdomen. - Nausea: occasional feeling of queasiness. - Dry mouth: reduced salivation. - Dizziness: transient light‑headedness.

Serious or Rare Side Effects: - Paralytic ileus: severe bowel obstruction requiring medical attention. - Cardiac arrhythmias: rare but potentially life‑threatening rhythm disturbances. - Severe allergic reaction: rash, swelling, or breathing difficulty.

Before using Imodium Classic, consider the following precautions: - Underlying infection: avoid if diarrhea is caused by bacterial or parasitic infection without medical guidance. - Severe hepatic impairment: use with caution as metabolism may be reduced. - Pediatric use: follow prescriber instructions for children, especially under two years of age. - Concomitant opioid therapy: monitor for additive effects on gut motility. - Pregnancy and breastfeeding: safety not established; consult a healthcare professional. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Loperamide may interact with several drug classes. Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase loperamide plasma levels and risk of toxicity. - Concomitant use with other opioids: can enhance opioid‑related adverse effects.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may exacerbate constipation. - Antidiarrheal agents (e.g., bismuth subsalicylate): overlapping mechanisms could lead to excessive slowing of gut motility. - Antifungal azoles (e.g., itraconazole): may modestly affect metabolism. - Certain antidepressants (e.g., duloxetine): monitor for additive CNS effects. - Herbal supplements containing St. John’s wort: may alter CYP3A4 activity.